Chris Nugent​​​​​​

Chris is Professor of Biomedical Engineering and is currently the Head of the School of Computing at Ulster University and director of the Pervasive Computing Research Centre.  He is also the co-Principal Investigator of the Connected Health Innovation Centre,  Principal Investigator at Ulster for the PWC Advanced Research and Engineering centre,  and co-investigator for the BT Ireland Innovation Centre. 

Chris was awarded a first class honours in BEng Electronic Systems and a PhD in Biomedical Engineering both from the University of Ulster in 1995 and 1998,  respectively.  He has also successfully completed a Post Graduate Certificate in University teaching at Ulster University in 2002 and during 2015 became a Fellow of the Higher Education Academy and was subsequently awarded a Senior Fellow of the Higher Education Academy in 2023.  He has held visiting Professorships at Halmstad University (Sweden) and the University of Florence (Italy) and is currently a visiting Professor in Pervasive and Mobile Computing at Lulea Technical University (Sweden),  a visiting Professor in Computing at Shandong Jianzhu University (China) and a Visiting Professor in Computing at Dalian University of Technology (China).  In 2016 he was awarded a Senior Distinguished Research Fellowship by Ulster University.

His research interests include the development and evaluation of technologies to support pervasive healthcare within smart environments. Specifically, this has involved research in the topics of mobile based reminding solutions, activity recognition and behaviour modelling and more recently technology adoption modelling.  

Session Living Lab

Ulster University’s Connected Health Living Lab

In this presentation I will present the details of Ulster University’s Connected Health Living Lab.  This will provide an overview of the physical space,  technology platforms,  research methodology and exemplar projects which have availed of the space.  The presentation will conclude with a vision for how the Living Lab will be developed in the short to medium term.